< Back to companies
Hayhurst Medical Technologies

Hayhurst Medical Technologies

Finding the curable cancer patients the system leaves behind.

Kansas City, Kansas, United States

AI / MLPre-Seed

Hayhurst Medical Technologies — Previous logo

Close
Hayhurst Medical Technologies — Previous logo
Share
Shareable draft
Hayhurst Medical Technologies logo
View pitch deck full screen
Get Involved in Hayhurst Medical Technologies

Photos & Videos

Previous hero

Previous hero

Previous hero

Previous hero

Previous logo

Previous logo

Leadership

Problem Statement

Every year, about 40,000 Americans qualify for a cancer surgery that could cure them, and roughly 90% are never found. The evidence is already in their records, sitting in radiology reports no one reads for candidacy. It is not a treatment gap; it is a detection and referral failure, and the patients missed most are in underserved, rural, and community settings.

Core Technology

Clinical AI that reads unstructured radiology and pathology reports at scale, extracting the findings that signal a curable patient and tracing each one back to its source sentence. An interpretable model scores surgical candidacy, maps it to the right specialist, and routes the patient, with a clinician approving every step, so there is no black box. Every case feeds a secure, outcome-linked cancer registry that improves the system with each patient.

Key Differentiators

The registry is the moat. Every case feeds a proprietary, outcome-linked dataset no incumbent holds and can’t easily assemble, so we get more accurate and more defensible with each patient. Interpretable, not a black box. Every finding traces back to its source sentence, and a clinician approves every step, which beats black-box AI on trust, adoption, and regulatory risk. We route; we don’t just flag. We assess surgical candidacy and send the patient to the right specialist. A clinician-plus-technical team. Two surgery-trained founders, one also an AI engineer, who live the problem, plus top CRS/HIPEC advisors and FDA-grade regulatory counsel. Live and deployed-ready today. Running on real de-identified clinical data, with EHR integration already in place at target hospitals.

Clinical Focus

Surgical oncology, beginning with peritoneal surface malignancy and candidacy for cytoreductive surgery with HIPEC, a potentially curative operation whose eligible patients are chronically under-identified and referred too late. The same detection-and-routing approach extends to other cancers where curable patients are missed. Decision support for the clinician making the referral, not autonomous diagnosis.

Target Customers

Hospitals and health systems, cancer centers, and the community, rural, and independent practices around them, the settings where curable patients are most often missed. We sell per-hospital software to the providers and programs that generate these patients, and partner with the surgical-oncology centers that receive the referrals. Research partners collaborate on the registry.

Product Stage

Beta

Company Info

Business Model
B2B SaaS. A recurring per-hospital software subscription for detection and navigation is the entry product and near-term revenue; a premium CT-imaging module follows as an upgrade once FDA-cleared; and the long-term asset is the proprietary, outcome-linked registry, licensable for research and real-world evidence. High software gross margins, low marginal cost per new hospital since EHR integration is already deployed. The software finds the patient; the data is the business.
Founded
2026
Total Funding
Only accessible to MedStartr community members. Join now
Website
hayhursttech.com

Categories

AI / ML

Clinical & IP

🔬

Clinical Validation

We validate candidacy against operative reports, the ground truth of what surgery actually found, and we deliberately test performance on incomplete, real-world community records. The system is live on real de-identified clinical data today. Our clinical advisors are the surgeons who perform this operation and confirm the miss is real. A leading clinical-AI accelerator gives us governed access to millions of de-identified records to validate at scale. Formal validation is ongoing; we are pre-deployment.

🛡️

IP Protection

patents pending

Only accessible to MedStartr community members. Join now

Reviews

★★★★★5.0 · 1 review
  • AnonymousNov 16, 2026
    ★★★★★5.0
    • Clinical Benefit Potential 5/5
    • Feasibility 5/5
    • Innovativeness 5/5
    • Fundability 5/5
    • Scalability 5/5
    • Presentation Quality 5/5

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Hayhurst Medical Technologies?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Hayhurst Medical Technologies
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free